Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Groll

Showing results (11-20 of 205) with videos related to

Pageof 21
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2012
Analysing properties of proteasome inhibitors using kinetic and X-ray crystallographic studiesNerea Gallastegui, Michael Groll
Chemical Reviews|December 21, 2016
The Methylerythritol Phosphate Pathway to IsoprenoidsAnnika Frank, Michael Groll
Chembiochem : a European Journal of Chemical Biology|September 14, 2019
Structures in Tetrahydrofolate Methylation in Desulfitobacterial Glycine Betaine Metabolism at Atomic ResolutionThomas Badmann, Michael Groll
Angewandte Chemie (International Ed. in English)|April 16, 2016
Rational Design of Proteasome Inhibitors as Antimalarial DrugsCamille Le Chapelain, Michael Groll
Angewandte Chemie (International Ed. in English)|June 20, 2012
Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug developmentEva Maria Huber, Michael Groll
Structure (London, England : 1993)|March 13, 2012
The 19S cap puzzle: a new jigsaw pieceEva M Huber, Michael Groll
Biochimica Et Biophysica Acta|January 31, 2013
Applied techniques for mining natural proteasome inhibitorsMartin L Stein, Michael Groll
Structure (London, England : 1993)|September 5, 2017
The Mammalian Proteasome Activator PA28 Forms an Asymmetric α<sub>4</sub>β<sub>3</sub> ComplexEva M Huber, Michael Groll
Chemical Communications (Cambridge, England)|November 1, 2011
Exploiting nature's rich source of proteasome inhibitors as starting points in drug developmentMelissa Ann Gräwert, Michael Groll
Current Topics in Medicinal Chemistry|August 10, 2011
Proteasome structure, function, and lessons learned from beta-lactone inhibitorsMichael Groll, Barbara C Potts
Pageof 21

Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2012
Analysing properties of proteasome inhibitors using kinetic and X-ray crystallographic studiesNerea Gallastegui, Michael Groll
Chemical Reviews|December 21, 2016
The Methylerythritol Phosphate Pathway to IsoprenoidsAnnika Frank, Michael Groll
Chembiochem : a European Journal of Chemical Biology|September 14, 2019
Structures in Tetrahydrofolate Methylation in Desulfitobacterial Glycine Betaine Metabolism at Atomic ResolutionThomas Badmann, Michael Groll
Angewandte Chemie (International Ed. in English)|April 16, 2016
Rational Design of Proteasome Inhibitors as Antimalarial DrugsCamille Le Chapelain, Michael Groll
Angewandte Chemie (International Ed. in English)|June 20, 2012
Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug developmentEva Maria Huber, Michael Groll
Structure (London, England : 1993)|March 13, 2012
The 19S cap puzzle: a new jigsaw pieceEva M Huber, Michael Groll
Biochimica Et Biophysica Acta|January 31, 2013
Applied techniques for mining natural proteasome inhibitorsMartin L Stein, Michael Groll
Structure (London, England : 1993)|September 5, 2017
The Mammalian Proteasome Activator PA28 Forms an Asymmetric α<sub>4</sub>β<sub>3</sub> ComplexEva M Huber, Michael Groll
Chemical Communications (Cambridge, England)|November 1, 2011
Exploiting nature's rich source of proteasome inhibitors as starting points in drug developmentMelissa Ann Gräwert, Michael Groll
Current Topics in Medicinal Chemistry|August 10, 2011
Proteasome structure, function, and lessons learned from beta-lactone inhibitorsMichael Groll, Barbara C Potts
Pageof 21